Nasdaq: CTY · Listed Oct 16, 2026
City Therapeutics IPO
$16.64
▼ -4.91%today · -7.56% since the $18.00 IPO price
15-minute delayed · as of 7:30:02 PM EST on Nov 18, 2026
City Therapeutics (CTY) priced its IPO at $18.00 a share and has traded on Nasdaq since Oct 16, 2026.
Last session · Nov 18, 2026
- Market cap
- $888.37M
- from the ticker reference
- Volume
- 206.95K
- shares, regular session
- VWAP
- $16.99
- the last price is -2.06% from the volume-weighted average
- Day range
- 16.26–18.75
- low to high
The trading numbers are from the last session, Nov 18, 2026.
The debut race
CTY against other big listings, as the percent change from each stock's own IPO price.
The first 30 trading days. Each point is the last regular-session trade of a day.
The first trading day.
The first trading day.
The IPO scoreboard
CTY against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.
| IPO | Raised | First trade | Day 1 close | Day 1 close, as a bar | Day 5 | Day 30 |
|---|---|---|---|---|---|---|
| City Therapeutics '26 | $200M | +27.78% | +22.17% | +14.94% | Not yet | |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% | |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% | |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% | |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% | |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% | |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |
Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.
The offering
The City Therapeutics IPO offers 11.11M shares to raise $200M, before any underwriters' option.
- Expected price range
- $17 to $19
- IPO price
- $18.00
- Shares offered
- 11.11M
- Money raised
- $200M
- Listing date
- Oct 16, 2026
- Exchange
- Nasdaq
- Security
- Ordinary Shares
Money raised, against the largest IPOs
- Alibaba '14$21.77B
- Facebook '12$18.41B
- Rivian '21$11.93B
- Uber '19$8.1B
- Arm '23$5.23B
- City Therapeutics$200M
Where CTY ranks
City Therapeutics's market cap against the largest US-listed companies.
Market cap, against the largest US-listed companies
- AAPL$5.12T
- MSFT$3.77T
- NVDA$3.65T
- GOOGL$3.47T
- AMZN$2.9T
- TSM$1.88T
- AVGO$1.69T
- META$1.58T
- TSLA$1.52T
- BRK.B$1.22T
- CTY$888.37M
What comes after the IPO
Options, short interest, analyst ratings, and fund holdings are not available on day one. Each starts on its own date. A date marked est. follows usual market practice.
Oct 16, 2026
First trade
Prices, bars, and snapshots
Oct 21, 2026 · est.
Options list
Option chain and open interest
Nov 5, 2026 · est.
First short interest
Short interest and daily short volume
Nov 10, 2026 · est.
Quiet period ends
Analyst ratings and price targets
Feb 14, 2027
First 13F deadline
Which funds hold the stock
Date not set
First earnings
Income statement and ratios
Apr 13, 2027 · est.
Lock-up expires
Insider sales on Form 4
Filings and the company
What City Therapeutics has disclosed to the SEC, and the basic facts about the listing.
8-K filings
Material events that City Therapeutics discloses to the SEC on Form 8-K.
- Charter amendmentOct 19, 2026
The Company filed its amended and restated certificate of incorporation (the "Amended and Restated Certificate") with the Secretary of State of the State of Delaware on October 19, 2026. The Amended and Restated Certificate ... (i) authorize 500,000,000 shares of common stock; (ii) eliminate all references to the previously-existing series of preferred stock; (iii) authorize 10,000,000 shares of undesignated preferred stock that may be issued from time to time by the Board in one or more series; and (iv) eliminate the ability of the Company's stockholders to take action by written consent in lieu of a meeting and call special meetings of stockholders.
About City Therapeutics
City Therapeutics Inc is a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics designed to silence the expression of disease-relevant proteins. Its current pipeline is focused on indications with unmet medical need, including thromboembolic diseases, Stargardt disease type 1 (Stargardt disease), and anemia of chronic disease.
- Ticker
- CTY
- Exchange
- Nasdaq
- Market
- stocks
- Type
- CS
- Currency
- USD
- Listed
- Oct 16, 2026
- Security
- Ordinary Shares
Frequently asked questions
What was the City Therapeutics IPO price?
$18.00 a share.
When did City Therapeutics go public?
City Therapeutics listed on Nasdaq on Oct 16, 2026 under the ticker CTY.
How much did the City Therapeutics IPO raise?
$200M, before any underwriters' option.
How did City Therapeutics open on its first day?
CTY first traded at $23.00, +27.78% from the IPO price of $18.00.
How did CTY close on its first day?
Its last regular-session trade was $21.99, +22.17% from the IPO price of $18.00.
What was the CTY first-day trading range?
$20.50 to $23.88 in the regular session.
How many CTY shares traded on the first day?
1.34M shares in the regular session.
How many shares did City Therapeutics sell in its IPO?
11.11M shares.
What exchange is CTY listed on?
City Therapeutics lists on Nasdaq under the ticker CTY.
Are the prices on this page real time?
No. Prices on this page are delayed 15 minutes. The Massive API and MCP server provide the most current data.
Build with Massive
Get the CTY data behind this page
| What the page shows | Endpoint |
|---|---|
| Offering terms and dates | /vX/reference/ipos |
| Price | /v3/snapshot |
| Chart, VWAP, and the market comparison | /v2/aggs/ticker/CTY/range/5/minute |
| Market cap | /v3/reference/tickers/CTY |
| News | /v2/reference/news |
| Filings | /vX/disclosures |
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.